Bullfrog Ai(NASDAQ) BFRGW

Bullfrog AI Holdings, Inc. is a digital biopharmaceutical company focused on leveraging artificial intelligence (AI) and machine learning (ML) to analyze healthcare datasets. The company aims to enhance medical research and treatment through its proprietary platform, bfLEAP, and has established significant licensing agreements with prestigious institutions.

Products and Services

• bfLEAP: An advanced AI/ML platform for analyzing clinical research data
• Licensing agreements for innovative treatments with George Washington University and Johns Hopkins University
• Focus on addressing various human conditions, including cancers and liver diseases

Growth Outlook

• Recent revenue of $215,385 indicates potential for growth in the biopharmaceutical sector
• Strong cash position with $6.9 million in cash and cash equivalents as of June 30, 2026
• Current ratio of 10.57 suggests robust liquidity to support operational needs

Financial Highlights

• Net income for Q2 2026 was -$1,371,530, reflecting ongoing investment in R&D
• Operating expenses totaled $1,525,960 in Q2 2026, indicating a focus on growth
• Gross profit margin of 49.63% in Q2 2026 shows potential for profitability

Bullfrog AI Holdings, Inc. operates in the healthcare information services industry, utilizing cutting-edge technology to improve medical outcomes. The company's innovative approach positions it well within a rapidly evolving market. Recent financial data highlights both challenges and opportunities, with significant investments in research and development aimed at driving future growth. The strong liquidity position and proprietary technology provide a foundation for potential investors to consider the company's long-term prospects.